VIVOS THERAPEUTICS, INC. (VVOS) Operating margin 2019–2025
VIVOS THERAPEUTICS, INC. (VVOS) operating margin by fiscal year — reported operating income divided by reported revenue.
-114.1%FY2025 · since FY2019: -92.8% → -114.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -114.1% | -39.7 pp |
| FY2024 | -74.3% | +51.0 pp |
| FY2023 | -125.3% | +30.9 pp |
| FY2022 | -156.2% | -35.5 pp |
| FY2021 | -120.7% | -28.6 pp |
| FY2020 | -92.1% | +0.7 pp |
| FY2019 | -92.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More VVOS financial trends
VVOS RevenueVVOS Net incomeVVOS Net marginVVOS Gross profitVVOS Gross marginVVOS Operating incomeVVOS Operating cash flowVVOS Free cash flowVVOS Capital expendituresVVOS Return on equityVVOS Stock buybacksVVOS Dividends paidVVOS Total assetsVVOS Total liabilitiesVVOS Shareholders’ equityVVOS overview →